Interleukin-1β mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures

Neurobiology of Disease

Volumn 25, Issue 1, 2007, Pages 92-104

  Saavedra, Ana ^a   Baltazar, Graça ^b   Duarte, Emília P ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Astrocytes; Crosstalk; Dopaminergic neurons; GDNF; IL 1 ; Injury; Microglia; Neuroprotection

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; LEVODOPA; MESSENGER RNA; OXIDIZING AGENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CELL; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GLIA CELL; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GLIA; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENTRAL TEGMENTUM; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DOPAMINE AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; LEVODOPA; MESENCEPHALON; NEUROGLIA; OXIDANTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; UP-REGULATION; VENTRAL TEGMENTAL AREA;

EID: 33751090113     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.08.019     Document Type: Article

References (81)

1. Acarin L., Gonzalez B., and Castellano B. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur. J. Neurosci. 12 (2000) 3505-3520
2. Akaneya Y., Takahashi M., and Hatanaka H. Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp. Neurol. 136 (1995) 44-52
3. Albrecht P.J., Dahl J.P., Stoltzfus O.K., Levenson R., and Levison S.W. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp. Neurol. 173 (2002) 46-62
4. Andre R., Pinteaux E., Kimber I., and Rothwell N.J. Differential actions of IL-1 alpha and IL-1 beta in glial cells share common IL-1 signalling pathways. NeuroReport 16 (2005) 153-157
5. Appel E., Kolman O., Kazimirsky G., Blumberg P.M., and Brodie C. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. NeuroReport 8 (1997) 3309-3312
6. Araujo D.M., and Cotman C.W. Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J. Neurosci. 12 (1992) 1668-1678
7. Baecker P.A., Lee W.H., Verity A.N., Eglen R.M., and Johnson R.M. Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene. Brain Res. Mol. Brain Res. 69 (1999) 209-222
8. Ban E.M., Sarlieve L.L., and Haour F.G. Interleukin-1 binding sites on astrocytes. Neuroscience 52 (1993) 725-733
9. Beck K.D., Irwin I., Valverde J., Brennan T.J., Langston J.W., and Hefti F. GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16 (1996) 665-673
10. Bolin L.M., Strycharska-Orczyk I., Murray R., Langston J.W., and Di MD. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J. Neurochem. 83 (2002) 167-175
11. Burke R.E., Antonelli M., and Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J. Neurochem. 71 (1998) 517-525
12. Carlson N.G., Wieggel W.A., Chen J., Bacchi A., Rogers S.W., and Gahring L.C. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163 (1999) 3963-3968
13. Castano A., Herrera A.J., Cano J., and Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem. 81 (2002) 150-157
14. Ciesielska A., Joniec I., Przybylkowski A., Gromadzka G., Kurkowska-Jastrzebska I., Czlonkowska A., and Czlonkowski A. Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease. Acta Neurobiol. Exp. (Wars) 63 (2003) 117-126
15. Davis A.E., Campbell S.J., Wilainam P., and Anthony D.C. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. Eur. J. Neurosci. 22 (2005) 2441-2450
16. DeKosky S.T., Styren S.D., O'Malley M.E., Goss J.R., Kochanek P., Marion D., Evans C.H., and Robbins P.D. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann. Neurol. 39 (1996) 123-127
17. Deniselle M.C., Lavista-Llanos S., Ferrini M.G., Lima A.E., Roldan A.G., and De Nicola A.F. In vitro differences between astrocytes of control and wobbler mice spinal cord. Neurochem. Res. 24 (1999) 1535-1541
18. Depino A., Ferrari C., Pott Godoy M.C., Tarelli R., and Pitossi F.J. Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions. J. Neuroimmunol. 168 (2005) 96-110
19. Dowd E., Monville C., Torres E.M., Wong L.F., Azzouz M., Mazarakis N.D., and Dunnett S.B. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur. J. Neurosci. 22 (2005) 2587-2595
20. Ericsson A., Liu C., Hart R.P., and Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361 (1995) 681-698
21. Fontana A., Kristensen F., Dubs R., Gemsa D., and Weber E. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J. Immunol. 129 (1982) 2413-2419
22. Friedman W.J. Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp. Neurol. 168 (2001) 23-31
23. Friedman W.J., Thakur S., Seidman L., and Rabson A.B. Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. J. Biol. Chem. 271 (1996) 31115-31120
24. Gadient R.A., Cron K.C., and Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117 (1990) 335-340
25. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., and Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380 (1996) 252-255
26. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., and Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9 (2003) 589-595
27. Giulian D., and Lachman L.B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228 (1985) 497-499
28. Giulian D., Baker T.J., Shih L.C., and Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164 (1986) 594-604
29. Giulian D., Young D.G., Woodward J., Brown D.C., and Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8 (1988) 709-714
30. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., Elsberry D.D., Klein M.C., Gerhardt G.A., and Gash D.M. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125 (2002) 2191-2201
31. Grunblatt E., Mandel S., Maor G., and Youdim M.B. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. J. Neurochem. 78 (2001) 1-12
32. Hanisch U.K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
33. Hebert G., Arsaut J., Dantzer R., and Demotes-Mainard J. Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin. Neurosci. Lett. 349 (2003) 191-195
34. Heese K., Hock C., and Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70 (1998) 699-707
35. Herx L.M., Rivest S., and Yong V.W. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 165 (2000) 2232-2239
36. Ho A., and Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci. 18 (1998) 5614-5629
37. Hudson J., Granholm A.C., Gerhardt G.A., Henry M.A., Hoffman A., Biddle P., Leela N.S., Mackerlova L., Lile J.D., and Collins F. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36 (1995) 425-432
38. Juric D.M., and Carman-Krzan M. Interleukin-1 beta, but not IL-1 alpha, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor. Int. J. Dev. Neurosci. 19 (2001) 675-683
39. Kobori N., Waymire J.C., Haycock J.W., Clifton G.L., and Dash P.K. Enhancement of tyrosine hydroxylase phosphorylation and activity by glial cell line-derived neurotrophic factor. J. Biol. Chem. 279 (2004) 2182-2191
40. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., and Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290 (2000) 767-773
41. Lawrence C.B., Allan S.M., and Rothwell N.J. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 10 (1998) 1188-1195
42. Lemke R., Hartlage-Rubsamen M., and Schliebs R. Differential injury-dependent glial expression of interleukins-1 alpha, beta, and interleukin-6 in rat brain. Glia 27 (1999) 75-87
43. Lieberman A.P., Pitha P.M., Shin H.S., and Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6348-6352
44. Lindgren N., Goiny M., Herrera-Marschitz M., Haycock J.W., Hokfelt T., and Fisone G. Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur. J. Neurosci. 15 (2002) 769-773
45. Lindholm D., Heumann R., Meyer M., and Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330 (1987) 658-659
46. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 932-940
47. Mandel S., Grunblatt E., Maor G., and Youdim M.B. Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray. Neurochem. Res. 27 (2002) 1231-1243
48. Martin D., Miller G., Cullen T., Fischer N., Dix D., and Russell D. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats. Eur. J. Pharmacol. 317 (1996) 247-256
49. Mason J.L., Suzuki K., Chaplin D.D., and Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21 (2001) 7046-7052
50. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., and Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180 (1994) 147-150
51. Mogi M., Togari A., Ogawa M., Ikeguchi K., Shizuma N., Fan D., Nakano I., and Nagatsu T. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum. Neurosci. Lett. 250 (1998) 25-28
52. Nagatsu T., and Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 11 (2005) 999-1016
53. Nagatsu T., Mogi M., Ichinose H., and Togari A. Cytokines in Parkinson's disease. J. Neural Transm. (2000) 143-151
54. Nieto-Sampedro M., and Berman M.A. Interleukin-1-like activity in rat brain: sources, targets, and effect of injury. J. Neurosci. Res. 17 (1987) 214-219
55. O'Neill L.A., and Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukocyte Biol. 63 (1998) 650-657
56. Parish C.L., Finkelstein D.I., Tripanichkul W., Satoskar A.R., Drago J., and Horne M.K. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J. Neurosci. 22 (2002) 8034-8041
57. Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., and Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol. 57 (2005) 298-302
58. Rothwell N.J., and Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23 (2000) 618-625
59. Rubio N. Demonstration of the presence of an interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler's virus. Immunology 82 (1994) 178-183
60. Saavedra A., Baltazar G., Carvalho C.M., and Duarte E.P. GDNF modulates HO-1 expression in substantia nigra postnatal cell cultures. Free Radical Biol. Med. 39 (2005) 1611-1619
61. Saavedra A., Baltazar G., Santos P., Carvalho C.M., and Duarte E.P. Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk. Neurobiol. Dis. 23 (2006) 533-542
62. Sairanen T.R., Lindsberg P.J., Brenner M., and Siren A.L. Global forebrain ischemia results in differential cellular expression of interleukin-1beta (IL-1beta) and its receptor at mRNA and protein level. J. Cereb. Blood Flow Metab. 17 (1997) 1107-1120
63. Salvatore M.F., Waymire J.C., and Haycock J.W. Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ. J. Neurochem. 79 (2001) 349-360
64. Samuelsson M., Fisher L., and Iverfeldt K. beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells. Int. J. Mol. Med. 16 (2005) 449-453
65. Saura J., Pares M., Bove J., Pezzi S., Alberch J., Marin C., Tolosa E., and Marti M.J. Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity. J. Neurochem. 85 (2003) 651-661
66. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., and Shanebeck K. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6155-6159
67. Sparacio S.M., Zhang Y., Vilcek J., and Benveniste E.N. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J. Neuroimmunol. 39 (1992) 231-242
68. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Naher-Noe M., and Thoenen H. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2 (1990) 69-76
69. Strijbos P.J., and Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15 (1995) 3468-3474
70. Takami Y., Motoki T., Yamamoto I., and Gohda E. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma. Biochem. Biophys. Res. Commun. 327 (2005) 212-217
71. Tanaka M., Ito S., and Kiuchi K. Novel alternative promoters of mouse glial cell line-derived neurotrophic factor gene. Biochim. Biophys. Acta 1494 (2000) 63-74
72. Tchelingerian J.L., Quinonero J., Booss J., and Jacque C. Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10 (1993) 213-224
73. Teismann P., Tieu K., Cohen O., Choi D.K., Wu dC., Marks D., Vila M., Jackson-Lewis V., and Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov. Disord. 18 (2003) 121-129
74. Verity A.N., Wyatt T.L., Hajos B., Eglen R.M., Baecker P.A., and Johnson R.M. Regulation of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells. J. Neurochem. 70 (1998) 531-539
75. Verity A.N., Wyatt T.L., Lee W., Hajos B., Baecker P.A., Eglen R.M., and Johnson R.M. Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J. Neurosci. Res. 55 (1999) 187-197
76. Vitkovic L., Bockaert J., and Jacque C. Inflammatory cytokines: neuromodulators in normal brain?. J. Neurochem. 74 (2000) 457-471
77. Wang J., Bankiewicz K.S., Plunkett R.J., and Oldfield E.H. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J. Neurosurg. 80 (1994) 484-490
78. Woodbury D., Schaar D.G., Ramakrishnan L., and Black I.B. Novel structure of the human GDNF gene. Brain Res. 803 (1998) 95-104
79. Xiao H., Hirata Y., Isobe K., and Kiuchi K. Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines. J. Neurochem. 82 (2002) 801-808
80. Xu K., and Dluzen D.E. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation. Exp. Neurol. 166 (2000) 450-457
81. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., and Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26 (1995) 676-680